RECURRENT UTERINE CORPUS SARCOMA

Clinical trials for RECURRENT UTERINE CORPUS SARCOMA explained in plain language.

Never miss a new study

Get alerted when new RECURRENT UTERINE CORPUS SARCOMA trials appear

Sign up with your email to follow new studies for RECURRENT UTERINE CORPUS SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

New hope for rare uterine cancer? trial tests avastin with chemo

Disease control Terminated

This phase 3 trial tested whether adding bevacizumab (Avastin) to standard chemotherapy (docetaxel and gemcitabine) helps people with advanced or recurrent uterine leiomyosarcoma. The study enrolled 107 participants but was terminated early. Researchers measured how long patients…

Matched conditions: RECURRENT UTERINE CORPUS SARCOMA

Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Jun 27, 2026 14:02 UTC

RECURRENT UTERINE CORPUS SARCOMA

Get alerted when new RECURRENT UTERINE CORPUS SARCOMA trials appear

New hope for rare uterine cancer? trial tests avastin with chemo